Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47 909 cases using the National Cancer Data Base

Annals of Diagnostic Pathology

Volumn 13, Issue 1, 2009, Pages 1-8

  Nese, Nalan ^a,b   Paner, Gladell P ^a   Mallin, Katherine ^c   Ritchey, Jamie ^c   Stewart, Andrew ^c   Amin, Mahul B ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

AJCC; Grade; NCDB; Renal cell carcinoma; Stage; TNM

Indexed keywords

ADULT; ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER GRADING; CANCER PATIENT; CANCER STAGING; DATA BASE; FEMALE; GROUPS BY AGE; HISTOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RESOURCE ALLOCATION; SURVIVAL RATE; TUMOR VOLUME; UNITED STATES;

ADOLESCENT; ADULT; CARCINOMA, RENAL CELL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; UNITED STATES; YOUNG ADULT;

EID: 57949098520     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2008.10.002     Document Type: Article

References (52)

1. Hock L.M., Lynch J., and Balaji K.C. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 167 (2002) 57-60
2. Hollingsworth J.M., Miller D.C., Daignault S., et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98 (2006) 1331-1334
3. Nguyen M.M., Gill I.S., and Ellison L.M. The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology, and end results program. J Urol 176 (2006) 2397-2400
4. Chow W.H., Devesa S.S., Warren J.L., et al. Rising incidence of renal cell cancer in the United States. JAMA 281 (1999) 1628-1631
5. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
6. Marshall F.F., Stewart A.K., and Menck H.R. The National Cancer Data Base: report on kidney cancers. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 80 (1997) 2167-2174
7. Amin M.B., Amin M.B., Tamboli P., et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26 (2002) 281-291
8. Cheville J.C., Lohse C.M., Zincke H., et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27 (2003) 612-624
9. Elmore J.M., Kadesky K.T., Koeneman K.S., et al. Reassessment of the 1997 TNM classification system for renal cell carcinoma. Cancer 98 (2003) 2329-2334
10. Frank I., Blute M.L., Leibovich B.C., et al. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 173 (2005) 1889-1892
11. Javidan J., Stricker H.J., Tamboli P., et al. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol 162 (1999) 1277-1281
12. Kattan M.W., Reuter V., Motzer R.J., et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63-67
13. Salama M.E., Guru K., Stricker H., et al. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors. J Urol 173 (2005) 1492-1495
14. Schlomer B., Figenshau R.S., Yan Y., et al. Pathological features of renal neoplasms classified by size and symptomatology. J Urol 176 (2006) 1317-1320
15. Zisman A., Pantuck A.J., Chao D., et al. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome. J Urol 166 (2001) 54-58
16. Eble J.N., Sauter G., Epstein J.I., et al. World Health Organization classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs (2004), IARC Press, Lyon, France
17. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual. 6th ed. (2002), Springer-Verlag, New York
18. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655-663
19. Paner G.P., Alvarado-Cabrero I., Moch H., et al. A novel nuclear grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Mod Pathol 19 (2006) 154A
20. Sika-Paotonu D., Bethwaite P.B., McCredie M.R., et al. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 30 (2006) 1091-1096
21. Epstein J.I., Amin M.B., Reuter V.R., et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22 (1998) 1435-1448
22. Percy C., Van Holten V., and Muir C. International Classification of Diseases for Oncology. 2nd ed (1990), World Health Organization, Geneva (ICD-0-2)
23. In: Bears O.H., Henson D.E., Hutter R.V.P., et al. (Eds). American Joint Committee on Cancer. Manual for staging of cancer. 4th ed (1992), J.B. Lippincott Company, Philadelphia 201-204
24. Cao Y., Paner G.P., Perry K.T., et al. Renal neoplasms in younger adults: analysis of 112 tumors from a single institution according to the new 2004 World Health Organization classification and 2002 American Joint Committee on Cancer Staging System. Arch Pathol Lab Med 129 (2005) 487-491
25. Abou El Fettouh H.I., Cherullo E.E., El-Jack M., et al. Sporadic renal cell carcinoma in young adults: presentation, treatment, and outcome. Urology 60 (2002) 806-810
26. Eggener S.E., Rubenstein J.N., Smith N.D., et al. Renal tumors in young adults. J Urol 171 (2004) 106-110
27. Sánchez-Ortiz R.F., Rosser C.J., Madsen L.T., et al. Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma. J Urol 171 (2004) 2160-2165
28. Gillett M.D., Cheville J.C., Karnes R.J., et al. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol 173 (2005) 1893-1896
29. Siemer S., Hack M., Lehmann J., et al. Outcome of renal tumors in young adults. J Urol 175 (2006) 1240-1243
30. Estrada C.R., Suthar A.M., Eaton S.H., et al. Renal cell carcinoma: Children's Hospital Boston experience. Urology 66 (2005) 1296-1300
31. In: Fleming I.D., Cooper J.S., Henson D.E., et al. (Eds). American Joint Committee on Cancer (AJCC) AJCC cancer staging manual. 5th ed (1997), Lippincott-Raven, Philadelphia 231-232
32. Guinan P., Saffrin R., Stuhldreher D., et al. Renal cell carcinoma: comparison of the TNM and Robson stage groupings. J Surg Oncol 59 (1995) 186-189
33. Hermanek P., and Schrott K.M. Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. J Urol 144 (1990) 238-242
34. Bretheau D., Lechevallier E., de Fromont M., et al. Prognostic value of nuclear grade of renal cell carcinoma. Cancer 76 (1995) 2543-2549
35. Farrow G., and Amin M.B. Protocol for the examination of specimens from patients with carcinomas of renal tubular origin, exclusive of Wilms tumor and tumors of urothelial origin: a basis for checklists. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 123 (1999) 23-27
36. Minervini A., Lilas L., Minervini R., et al. Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma. Long-term analysis in 213 patients. Cancer 94 (2002) 2590-2595
37. Al-Aynati M., Chen V., Salama S., et al. Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Pathol Lab Med 127 (2003) 593-596
38. Ficarra V., Martignoni G., Maffei N., et al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 103 (2005) 68-75
39. Lang H., Lindner V., de Fromont M., et al. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: assessment of 241 patients with >15-year follow-up. Cancer 103 (2005) 625-629
40. Delahunt B., Sika-Paotonu D., Bethwaite P.B., et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 31 6 (2007) 957-960
41. Amin M.B., Corless C.L., Renshaw A.A., et al. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 21 (1997) 621-635
42. Sorbellini M., Kattan M.W., Snyder M.E., et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173 (2005) 48-51
43. Zisman A., Pantuck A.J., Dorey F., et al. Improved prognostication of renal cell carcinoma using an integrated system. J Clin Oncol 19 (2001) 1649-1657
44. Frank I., Blute M.L., Cheville J.C., et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395-2400
45. Tsui K., Shvarts O., Smith R.B., et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 163 (2000) 1090-1095
46. Ficarra V., Novara G., Galfano A., et al. The "stage, size, grade and necrosis" score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma. BJU Int (2008) [Electronic publication ahead of print]
47. Beck S.D., Patel M.I., Snyder M.E., et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 11 (2004) 71-77
48. Gudbjartsson T., Hardarson S., Petursdottir V., et al. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol 48 (2005) 593-600
49. Moch H., Gasser T., Amin M.B., et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma. A Swiss experience with 588 tumors. Cancer 89 (2000) 604-614
50. Patard J.J., Leray E., Rioux-Leclercq N., et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23 (2005) 2763-2771
51. Amin M.B., Paner G.P., Alvarado-Cabrero I., et al. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol (2008) [in press]
52. Kane C.J., Mallin K., Ritchey J., et al. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113 1 (2008) 78-83